As of May 23
| +0.08 / +0.66%|
The 8 analysts offering 12-month price forecasts for Cross Country Healthcare Inc have a median target of 12.50, with a high estimate of 15.00 and a low estimate of 11.00. The median estimate represents a +2.29% increase from the last price of 12.22.
The current consensus among 10 polled investment analysts is to Hold stock in Cross Country Healthcare Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.